Opko Health ( ($OPK) ) just unveiled an update. On September 15, 2025, OPKO Health, Inc. completed the sale of certain assets ...

Labcorp has completed its previously announced acquisition of select assets of BioReference Health, a wholly owned subsidiary ...

The United States Drug Abuse Testing Market is projected to grow significantly, reaching US$ 3.71 billion by 2033, up from ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today ...

此项交易价值高达2.25亿美元，包括BioReference Health在美国各地专注于肿瘤学和肿瘤相关临床检测服务的实验室检测业务。Labcorp在交易完成时支付了1.925亿美元，并可能根据业绩表现额外支付3250万美元。根据 InvestingPro 数据，Labcorp年收入达135亿美元，并保持强劲的财务健康评分，表明其具备进行战略收购的强大能力。

The firm's commercialization push is fueled by $35.6 million from a recent Series C financing and a $15.5 million ...